OMERACT: An international initiative to improve outcome measurement in rheumatology

被引：407

作者：

Tugwell, Peter ^{[1
,2
]}

Boers, Maarten ^{[3
]}

Brooks, Peter ^{[4
]}

Simon, Lee ^{[5
,6
]}

Strand, Vibeke ^{[7
]}

Idzerda, Leanne ^{[8
]}

机构：

[1] Univ Ottawa, Dept Med, Ottawa, ON, Canada

[2] Inst Populat Hlth, Ottawa, ON, Canada

[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands

[4] Univ Queensland, Fac Hlth Sci, Brisbane, Qld, Australia

[5] Harvard Med Sch, Boston, MA USA

[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[7] Stanford Univ, Div Immunol, Stanford, CA 94305 USA

[8] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada

来源：

TRIALS | 2007年 / 8卷 / 1期

关键词：

D O I：

10.1186/1745-6215-8-38

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

OMERACT is the acronym for an international, informally organized network initiated in 1992 aimed at improving outcome measurement in rheumatology. Chaired by an executive committee, it organizes consensus conferences in a 2-yearly cycle that circles the globe. Data driven recommendations are prepared and updated by expert working groups. Recommendations include core sets of measures for most of the major rheumatologic conditions. Since 2002 patients have been actively engaged in the process.

引用

页数：6

共 21 条

[1]

BOERS M, 1994, J RHEUMATOL, V21, P86

[2]

Boers M, 1998, J RHEUMATOL, V25, P198

[3]

BOERS M, 1995, BAILLIERE CLIN RHEUM, V9, P305, DOI 10.1016/S1521-6942(06)80005-7

[4]

Brooks P., 2001, Rheumatology (Oxford), V40, P896, DOI 10.1093/rheumatology/40.8.896

[5]

Gossec L, 2005, J RHEUMATOL, V32, P2447

[6]

Lassere MND, 1999, J RHEUMATOL, V26, P459

[7] Update on outcome assessment in rheumatic disorders [J].

Molenaar, E ;

van der Heijde, D ;

Boers, M .

CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (02) :91-98

[8] Recent developments for optimal end-points in rheumatoid arthritis clinical studies [J].

Molenaar, ETM ;

Boers, M ;

Brooks, PM ;

Simon, L ;

Strand, V ;

Tugwell, P .

DISEASE MANAGEMENT & HEALTH OUTCOMES, 2000, 8 (02) :87-97

[9]

MUIRDEN KD, 1993, J RHEUMATOL, V20, P527

[10]

OMERACT, OMERACT OUTC MEAS RH

← 1 2 3 →